The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial
Felix Böhm(Karolinska University Hospital), Stefan James(Uppsala University), Andrejs Ērglis(Pauls Stradiņš Clinical University Hospital), Goran Stanković(University of Belgrade), Mika Laine(Helsinki University Hospital), Brynjólfur Mogensen(Karolinska University Hospital), Thomas Engstrøm(University of Copenhagen), Andreas Rück(Karolinska University Hospital), Carl Schultz(The University of Western Australia), Colin Berry(University of Glasgow), Oskar Angerås(Sahlgrenska University Hospital), Claes Held(Uppsala University), Eigil Fossum(Oslo University Hospital), Madhav Menon(Karolinska University Hospital), Ollie Östlund(Karolinska University Hospital), Christoph Liebetrau(Kerckhoff Klinik)
Cited by 13
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k